Clinical Trials in Philadelphia

Showing 1861-1880 of 20,904 trials

FDG-PET Imaging in Complicated Diabetic Foot

NCT00194298

The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities, including MRI, and patient outcome. We expect that at the completion of the proposed research, the role of these powerful imaging modalities will be clearly defined in the management of patients with this challenging and serious complication.

Diabetic Foot Disease

University of Pennsylvania240 participantsStarted Oct 2002

Philadelphia, Pennsylvania, United States

Active Not Recruiting< 1 mile

A Study of miRNA 371 in Patients With Germ Cell Tumors

NCT04435756

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

Germ Cell TumorMetachronous Malignant NeoplasmSeminoma+4 more

SWOG Cancer Research Network956 participantsStarted Jul 2020

Gilbert, Arizona, United States • Kingman, Arizona, United States • Tucson, Arizona, United States +421 more locations

FDG-PET Imaging in Complicated Diabetic Foot

A Study of miRNA 371 in Patients With Germ Cell Tumors

Find Trials by Condition in Philadelphia

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

The Fourth Left Atrial Appendage Occlusion Study

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)